Hikma Pharmaceuticals【HIK】銘柄情報

Hikma Pharmaceuticals Plc (HIK) 銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

通貨

1,457.00

( 0.41% )

買値

1,464.00

売値

1,466.00

出来高

1,683,321

1,420.00 日の範囲 1,478.00

1,187.00 52 週間の範囲 2,074.00

時価総額

3.104B

前日終値

1,451.00

始値

1,420.00

時刻

3100

1457

(O)

最終取引時間

財務取引量

24,560,971p

VWAP

1,459.0783

平均取引量 (3 か月)

1,046,449p

発行済株式数

213,030,512

配当利回り

0.84

PER

10.98

1 株当たり利益 (EPS)

1.81

歳入

3.35B

純利益

402M

Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, specialty, and branded pharmaceutical products. The company operates through three segments: Injectables, Hikma Rx, and Branded. The Injectables segment provides generic and specialty injectable products primari... Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, specialty, and branded pharmaceutical products. The company operates through three segments: Injectables, Hikma Rx, and Branded. The Injectables segment provides generic and specialty injectable products primarily for use in hospitals. The Branded segment offers branded generics and in-licensed products to retail and hospital markets. The Hikma Rx segment offers oral, respiratory, and other generic and specialty products for the retail market. It provides its products in various therapeutic areas, including respiratory, oncology, and pain management. The company also offers its products in solid, semi-solid, liquid, and injectable dosage forms. It operates in the United Kingdom, Europe, North America, the Middle East, North Africa, and internationally. Hikma Pharmaceuticals PLC was founded in 1978 and is headquartered in London, United Kingdom. 詳細を表示

セクター

Healthcare

業界

Pharmaceuticals

ウェブサイト

www.hikma.com

本社

London, United Kingdom

設立

1978

Hikma Pharmaceuticals Plc is listed in the Healthcare sector of the ロンドン証券取引所 with ticker HIK. The last closing price for Hikma Pharmaceuticals was 1,451p. Over the last year, Hikma Pharmaceuticals shares have traded in a share price range of 1,187.00p to 2,074.00p.

Hikma Pharmaceuticals currently has 213,030,512 shares in issue. The market capitalisation of Hikma Pharmaceuticals is £3.10 billion. Hikma Pharmaceuticals has a price to earnings ratio (PE ratio) of 10.98.

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-13	-0.884353741497	1470	1500	1420	576926	1463.81151669	DE
4	-25	-1.68690958165	1482	1503	1397	808573	1455.13077086	DE
12	193	15.2689873418	1264	1503	1236	873913	1389.77339653	DE
26	-45	-2.99600532623	1502	1691	1187	1119494	1388.0250323	DE
52	-597	-29.0652385589	2054	2074	1187	880450	1523.59647528	DE
156	-470	-24.3902439024	1927	2360	1187	609514	1757.45850387	DE
260	-925	-38.8329135181	2382	2703	1174.5	602832	1773.15572564	DE